Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Illumina's Quest to Acquire GRAIL Fail?

TheMotleyFool

0 0

Could Illumina's Quest to Acquire GRAIL Fail?

Illumina (NASDAQ: ILMN) spun off liquid biopsy company GRAIL a few years ago. But the big genomic sequencing pioneer now wants GRAIL back. However, there's a potential wrinkle that could derail Illumina's plans. In this Motley Fool Live video recorded on March 31, Motley Fool contributors Keith Speights and Brian Orelli discuss whether Illumina's quest to acquire GRAIL could ultimately fail.

Source Fool.com

Like: 0

ILMN

Share